Insmed (INSM) Amortization - Intangibles (2018 - 2026)
Insmed (INSM) recorded quarterly Amortization - Intangibles of $2.1 million in Q1 2026, up 7.43% quarter-over-quarter from $1.9 million in Q4 2025, and up 64.77% on a YoY basis from $1.3 million in Q1 2025.
Insmed (INSM) Amortization - Intangibles (2018 - 2026) Analysis & Trends
Insmed's Amortization - Intangibles history runs 9 years deep, the most recent figure standing at $2.1 million for Q1 2026.
- In Q1 2026, Amortization - Intangibles rose 64.77% year-over-year to $2.1 million; the TTM figure through Mar 2026 stood at $6.8 million (up 34.98% YoY), while the FY2025 annual figure was $6.0 million, up 18.78% from the prior year.
- Amortization - Intangibles was $2.1 million for Q1 2026 at Insmed, up from $1.9 million in the prior quarter.
- In the past five years, Amortization - Intangibles ranged from a high of $2.1 million in Q1 2026 to a low of $1.3 million in Q1 2022.
- Historically, Amortization - Intangibles has averaged $1.4 million across 5 years, with a median of $1.3 million in 2022.
- The sharpest annual moves came in 2022 and 2026: Amortization - Intangibles decreased 0.08% in 2022, then jumped 64.77% in 2026.
- A 5-year view of Amortization - Intangibles shows it stood at $1.3 million in 2022, then dropped by 0.08% to $1.3 million in 2023, then changed by 0.0% to $1.3 million in 2024, then jumped by 53.37% to $1.9 million in 2025, then grew by 7.43% to $2.1 million in 2026.
- The last three Amortization - Intangibles figures came in at $2.1 million (Q1 2026), $1.9 million (Q4 2025), and $1.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Insmed | 19.79 Bn | 18.57 Bn | 258.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.08 Mn |
| Dec 31, 2025 | 1.94 Mn |
| Sep 30, 2025 | 1.54 Mn |
| Jun 30, 2025 | 1.26 Mn |
| Mar 31, 2025 | 1.26 Mn |
| Dec 31, 2024 | 1.26 Mn |
| Sep 30, 2024 | 1.26 Mn |
| Jun 30, 2024 | 1.26 Mn |
| Mar 31, 2024 | 1.26 Mn |
| Dec 31, 2023 | 1.26 Mn |
| Sep 30, 2023 | 1.26 Mn |
| Jun 30, 2023 | 1.26 Mn |
| Mar 31, 2023 | 1.26 Mn |
| Dec 31, 2022 | 1.26 Mn |
| Sep 30, 2022 | 1.26 Mn |
| Jun 30, 2022 | 1.26 Mn |
| Mar 31, 2022 | 1.26 Mn |
| Dec 31, 2021 | 1.26 Mn |
| Sep 30, 2021 | 1.26 Mn |
| Jun 30, 2021 | 1.26 Mn |